Scottish Government calling for more transparency in SMC decision-making

摘要

DECISIONS about making new medicines available within NHS Scotland should be made in a more open and transparent way. This is the conclusion of a Scottish Government review published on 3 May 2013. NHS advice on new medicines is currently provided by the Scottish Medicines Consortium. The review concluded that the SMC has efficient, robust, independent and timely processes. However, it recommends that the SMC should meet in public so that pa- tients, the public, patient group representatives, health professionals and the pharmaceutical industry can observe the appraisal process. After the public hearing, a decision could be taken in private.